Mindwalk Holdings Corp (HYFT) Stock Price, Quote & News

teddiskim Sep. 7 at 2:37 PM

$HYFT what is this gibberish

1 · Reply

local42r Sep. 7 at 12:07 AM

$HYFT The next news will blow this past 4.50. Know what you own.

1 · Reply

BigToober Sep. 6 at 11:11 PM

$HYFT

0 · Reply

NyseDayTrader Sep. 6 at 6:35 PM

$HYFT ImmunoPrecise Antibodies just changed to MindWalk Holdings-and it's huge. They build bio-native AI engine, LensAI with HYFT tech, that crunches multi-omics data and lab stuff to spot patterns in biology no human could. Think faster drug discovery: mapping epitopes, designing molecules, vaccines-you name it. Their shift to SaaS and DaaS means scalable partnerships, turning insights into real meds quicker. In medicine's future? Game-changer for chronic diseases, personalized therapies, cutting trial times by years. We're talking safer, targeted treatments

0 · Reply

prpntr Sep. 6 at 5:59 PM

$HYFT

0 · Reply

windswept Sep. 6 at 5:15 PM

$HYFT

0 · Reply

NyseDayTrader Sep. 6 at 3:34 PM

$HYFT Thanks for reaching out, We have updated the ticker to HYFT. Thanks for keeping us on our toes! If you would like to request further tickers to be added or updated please let us know.

0 · Reply

kozyman87 Dec. 28 at 2:57 PM

$HYFT https://twitter.com/kozyman87/status/1608114714185195520?s=46&t=Qkz-Bynn3_-IRMZ272qW-w

0 · Reply

kozyman87 Dec. 28 at 2:37 PM

$ABCL take a peak at cross town competition $HYFT , moving ahead on multiple fronts…Ai is world class drug discovery on steroids,#1 wet lab with CRO kicking it 🆙 and don’t forget their 💯owned Pipeline in Talem Therapeutics

0 · Reply

Doozio Dec. 24 at 10:11 PM

They ❤️ to Monday 🐑em before a 🧠 FRYday close when da 🧠 is coming out da 📦. They shakem early then stirrem n 🍹 ⬆️ that $IPA late! Will it tighten up for FOUR moar…? 🧠👀😇📦

0 · Reply

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

Sep 2, 2025, 8:01 AM EDT - 5 days ago

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York

Aug 27, 2025, 8:22 AM EDT - 11 days ago

ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation

Aug 6, 2025, 8:00 AM EDT - 4 weeks ago

AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd.

Aug 6, 2025, 8:00 AM EDT - 4 weeks ago

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation

Jul 29, 2025, 12:39 PM EDT - 5 weeks ago

ImmunoPrecise Antibodies Ltd. (IPA) Q4 2025 Earnings Conference Call Transcript

Jul 29, 2025, 8:28 AM EDT - 5 weeks ago

ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA

Jul 24, 2025, 8:22 AM EDT - 6 weeks ago

ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic

Jul 21, 2025, 8:28 AM EDT - 6 weeks ago

ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board

Jul 16, 2025, 8:05 AM EDT - 7 weeks ago

IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025

Jul 14, 2025, 8:01 AM EDT - 7 weeks ago

ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 7, 2025, 9:00 AM EDT - 2 months ago

ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors

Jul 3, 2025, 8:19 AM EDT - 2 months ago

ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data

Jun 24, 2025, 7:02 AM EDT - 2 months ago

ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology

AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies

Jun 12, 2025, 8:01 AM EDT - 3 months ago

IPA's LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed

AMD

Apr 11, 2025, 8:40 AM EDT - 5 months ago

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods

Mar 28, 2025, 12:59 PM EDT - 5 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript

Mar 28, 2025, 8:01 AM EDT - 5 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025

Mar 13, 2025, 7:02 AM EDT - 6 months ago

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025

Mar 11, 2025, 10:17 PM EDT - 6 months ago

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment

Jan 22, 2025, 7:02 AM EST - 8 months ago

$116 Million Multifamily Asset Sale in Central California Coast Region Brokered by Marcus & Millichap's Institutional Property Advisors

MMI

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases

Dec 23, 2024, 8:30 AM EST - 9 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025

IPA to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Dec 4, 2024, 8:00 AM EST - 9 months ago

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024

Oct 21, 2024, 9:00 AM EDT - 11 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025

Sep 9, 2024, 9:11 AM EDT - 1 year ago

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024

teddiskim Sep. 7 at 2:37 PM

$HYFT what is this gibberish

1 · Reply

local42r Sep. 7 at 12:07 AM

$HYFT The next news will blow this past 4.50. Know what you own.

1 · Reply

BigToober Sep. 6 at 11:11 PM

$HYFT

0 · Reply

NyseDayTrader Sep. 6 at 6:35 PM

0 · Reply

prpntr Sep. 6 at 5:59 PM

$HYFT

0 · Reply

windswept Sep. 6 at 5:15 PM

$HYFT

0 · Reply

NyseDayTrader Sep. 6 at 3:34 PM

$HYFT Thanks for reaching out, We have updated the ticker to HYFT. Thanks for keeping us on our toes! If you would like to request further tickers to be added or updated please let us know.

0 · Reply

kozyman87 Dec. 28 at 2:57 PM

$HYFT https://twitter.com/kozyman87/status/1608114714185195520?s=46&t=Qkz-Bynn3_-IRMZ272qW-w

0 · Reply

kozyman87 Dec. 28 at 2:37 PM

0 · Reply

Doozio Dec. 24 at 10:11 PM

0 · Reply

Doozio Dec. 24 at 10:06 PM

Merry 🎅 eve YO 🧠🐑 fooks! Da huckleberries r fresh some 🧠 $IPA. 🧠👀😇📦🍺

1 · Reply

NyseDayTrader Dec. 23 at 7:18 PM

$HYFT added today

0 · Reply

BigRig_Trader Dec. 23 at 4:44 PM

$HYFT https://twitter.com/bigrig_trader/status/1606329707854700545?s=46&t=zSgy7gBS35w042GI2zfucA

0 · Reply

Huskerman Dec. 23 at 4:41 PM

$HYFT is there going to be an early xmas gift or just more 20% swings...asking for a friend

0 · Reply

BigRig_Trader Dec. 22 at 5:55 PM

$HYFT https://twitter.com/bigrig_trader/status/1605974125645664259?s=46&t=En6KTQNTXra98_tVU4mbVA

0 · Reply

kozyman87 Dec. 22 at 3:10 PM

$HYFT video embedded in my tweet is mind blowing 🤯

2 · Reply

kozyman87 Dec. 22 at 2:11 PM

$HYFT https://twitter.com/kozyman87/status/1605927586613411841?s=46&t=VK-6QRi3e9TVRDyVawg2Dg

0 · Reply

kozyman87 Dec. 22 at 4:28 AM

$HYFT https://twitter.com/kozyman87/status/1605775840821727232?s=46&t=dmWZabHUpEYI4iW0aIliFQ

0 · Reply

kozyman87 Dec. 22 at 4:26 AM

$HYFT https://twitter.com/kozyman87/status/1605775839047651328?s=46&t=dmWZabHUpEYI4iW0aIliFQ

0 · Reply

Market Cap	N/A
Revenue (ttm)	24.52M
Net Income (ttm)	-30.23M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	-123.30%
Debt to Equity Ratio	0.49

Volume	811,100
Avg Vol	1,853,810
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	8%
Beta	N/A
Analysts	Sell
Price Target	$4.00